Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 61/199,179, filed Nov 13, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,415,297 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 8,592,371 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 8,772,328 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 8,951,965 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 9,138,426 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 9,278,976 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 9,403,790 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 8,143,289 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.